Real-time measurement of in vitro peptide binding to soluble HLA-A*0201 by fluorescence polarization.
about
Natural epitope variants of the hepatitis C virus impair cytotoxic T lymphocyte activityCharacterization of structural features controlling the receptiveness of empty class II MHC molecules.Abacavir induces loading of novel self-peptides into HLA-B*57: 01: an autoimmune model for HLA-associated drug hypersensitivity.Direct interrogation of viral peptides presented by the class I HLA of HIV-infected T cells.Identification of conserved and HLA promiscuous DENV3 T-cell epitopes.Real-time, high-throughput measurements of peptide-MHC-I dissociation using a scintillation proximity assay.Resolving multiple protein-peptide binding events: implication for HLA-DQ2 mediated antigen presentation in celiac disease.Information technologies for vaccine research.Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7Human Leukocyte Antigen-Presented Macrophage Migration Inhibitory Factor Is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer.HLA class I molecules consistently present internal influenza epitopesT-cell tolerance for variability in an HLA class I-presented influenza A virus epitope.Human herpesvirus 7 U21 tetramerizes to associate with class I major histocompatibility complex molecules.Peptide-MHC class I stability is a better predictor than peptide affinity of CTL immunogenicity.Measurement of MHC/peptide interactions by gel filtration or monoclonal antibody capture.Novel cellular microarray assay for profiling T-cell peptide antigen specificities.A Recurrent Mutation in Anaplastic Lymphoma Kinase with Distinct Neoepitope Conformations.Explanation for HLA-B*57:01-linked immune-mediated abacavir-induced hypersensitivity.
P2860
Q33812154-1D0DAC2F-AA5D-49E7-AF4F-FA6E2B1D8570Q33886577-C07738D5-FA4E-4938-9A37-B8D39E4E52E9Q34140322-56FA985A-F9BA-4586-8C78-825DF758B411Q34594624-19705E0B-0A67-4267-952C-A1E9FD0ACE0DQ35018972-49C1706E-46FA-4396-8F87-F8D32C50AD61Q35124550-DC96E15E-1D28-4DC8-BD83-5E2B9F981C8BQ36055610-545AA49E-5298-443B-8FAD-320DC68B5FBCQ36198676-58DDB127-D531-4314-BD04-9B62F049F915Q36499204-9773BA08-902C-454F-9FE6-3D9E07982366Q36563742-848E1E0E-4C08-4596-9296-286D2B5E1E0EQ37062068-685F5D96-BFC9-4202-86F4-921EA962A81DQ37333937-AB908E3B-4FDA-48C2-912D-ED84E0DA24C3Q37643735-188BD334-E377-4578-BCF3-7D6624B19A23Q39606015-5EF99626-A385-4048-85B4-EA5979A2CD66Q39849181-33D7DDC5-2A50-4C2D-9A07-0F872AAC7767Q42121659-D4BB7AB6-BF66-435C-B154-EC34DBFD3842Q49404911-004621B0-256C-4039-9B2F-4FA690C8E643Q53353947-7DAAD066-E999-40C3-BC30-D52CE0F22FB1
P2860
Real-time measurement of in vitro peptide binding to soluble HLA-A*0201 by fluorescence polarization.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Real-time measurement of in vi ...... by fluorescence polarization.
@en
Real-time measurement of in vi ...... by fluorescence polarization.
@nl
type
label
Real-time measurement of in vi ...... by fluorescence polarization.
@en
Real-time measurement of in vi ...... by fluorescence polarization.
@nl
prefLabel
Real-time measurement of in vi ...... by fluorescence polarization.
@en
Real-time measurement of in vi ...... by fluorescence polarization.
@nl
P2093
P356
P1433
P1476
Real-time measurement of in vi ...... by fluorescence polarization.
@en
P2093
Christopher F Giberson
Heather D Hickman-Miller
Rico Buchli
Rodney S VanGundy
Wilfried Bardet
William H Hildebrand
P304
14852-14863
P356
10.1021/BI048580Q
P407
P577
2004-11-01T00:00:00Z